Nkarta (NKTX) Non-Current Assets (2019 - 2026)

Nkarta's quarterly Non-Current Assets came in at $136.2 million in Q1 2026, down 31.58% year-on-year from $199.1 million in Q1 2025, and up 11.91% quarter-over-quarter from $121.7 million in Q4 2025.

Nkarta has reported Non-Current Assets for 8 years, with the latest figure at $136.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 31.58% year-over-year to $136.2 million; the trailing twelve-month figure through Mar 2026 stood at $547.6 million (down 38.55% YoY), and the FY2025 full-year result was $121.7 million, down 46.59% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $136.2 million, up from $121.7 million in the prior quarter.
  • The five-year high for Non-Current Assets was $241.9 million in Q3 2024, with the low at $83.1 million in Q1 2022.
  • Average Non-Current Assets over 5 years is $145.7 million, with a median of $134.2 million recorded in 2024.
  • Year-over-year, Non-Current Assets surged 299.14% in 2022 and slumped 46.59% in 2025.
  • Tracing NKTX's Non-Current Assets over 5 years: stood at $112.2 million in 2022, then grew by 12.08% to $125.8 million in 2023, then soared by 81.11% to $227.9 million in 2024, then plunged by 46.59% to $121.7 million in 2025, then climbed by 11.91% to $136.2 million in 2026.
  • The last three Non-Current Assets figures came in at $136.2 million (Q1 2026), $121.7 million (Q4 2025), and $138.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 4.56 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 62,953.78
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 5.83 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.75 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 22.66 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 910.24 Mn
10 Nkarta 232.80 Mn 232.80 Mn - 136.19 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 136.19 Mn
Dec 31, 2025 121.70 Mn
Sep 30, 2025 137.96 Mn
Jun 30, 2025 151.74 Mn
Mar 31, 2025 199.06 Mn
Dec 31, 2024 227.87 Mn
Sep 30, 2024 241.88 Mn
Jun 30, 2024 222.29 Mn
Mar 31, 2024 134.16 Mn
Dec 31, 2023 125.81 Mn
Sep 30, 2023 124.68 Mn
Jun 30, 2023 142.30 Mn
Mar 31, 2023 125.98 Mn
Dec 31, 2022 112.25 Mn
Sep 30, 2022 102.88 Mn
Jun 30, 2022 86.26 Mn
Mar 31, 2022 83.08 Mn
Dec 31, 2021 28.12 Mn
Sep 30, 2021 27.83 Mn
Jun 30, 2021 25.18 Mn
Mar 31, 2021 23.46 Mn
Dec 31, 2020 18.82 Mn
Sep 30, 2020 18.90 Mn
Jun 30, 2020 21.32 Mn
Dec 31, 2019 10.95 Mn